-36%

Sermorelin Acetate 2mg vial high-purity GHRH 1-29 for pituitary research.

Sermorelin (GHRH 1-29) 2mg | High-Purity Research Peptide | $\geq$99% Purity

Name: Sermorelin (GHRH 1-29) 2mg | High-Purity Research Peptide | $geq$99% Purity - TITANFORGE LABS
Price: 87.00 USD
Availability: InStock

Original price was: $135.00.Current price is: $87.00.

Sermorelin (as Sermorelin Acetate) is a truncated, 29-amino acid polypeptide that represents the functional fragment of naturally occurring Growth Hormone Releasing Hormone (GHRH). As the shortest fully functional fragment of GHRH, Sermorelin is highly sought after in clinical research for its ability to stimulate the pituitary gland to produce and secrete endogenous growth hormone. By mimicking the body’s natural signaling, it provides a safer, more regulated approach to investigating GH elevation compared to synthetic growth hormone.

Categories: GROWTH HORMONE SECRETAGOGUES, PERFORMANCE PEPTIDES Tags: Bio-identical Peptides, GHRH, Growth Hormone Releasing Hormone, Metabolic Research, Pituitary Health, Sermorelin

Description

Sermorelin: The Bio-Identical Catalyst for Endogenous GH Research

The Biochemistry of Sermorelin (GHRH 1-29)

Sermorelin is often referred to as GHRH 1-29 because it contains the first 29 amino acids of the 44-amino acid sequence of human growth hormone-releasing hormone. Research confirms that this specific 29-amino acid chain contains the full biological activity required to bind to the GHRH receptors in the anterior pituitary. Unlike exogenous GH, which can shut down the body’s natural production, Sermorelin works within the endocrine system’s feedback loops, preserving the integrity of the Somatotropic Axis.

Mechanism of Action: Preserving the Pituitary Pulse

The primary research value of Sermorelin lies in its “physiologic” approach to growth hormone stimulation:

Receptor Specificity: Sermorelin binds directly to the GHRH receptors on somatotroph cells.
Pulsatile Release: It encourages the release of GH in a pulsatile manner, which is crucial for preventing receptor desensitization and maintaining natural circadian rhythms.
Somatostatin Antagonism: High-level studies indicate that Sermorelin can help overcome the inhibitory effects of Somatostatin, the “off-switch” for growth hormone production.

Why Researchers Prefer Sermorelin Over Synthetic GH

Self-Limiting Nature: Sermorelin is subject to natural negative feedback by the hormone IGF-1; this means that in a research setting, the body is less likely to produce “too much” GH, reducing the risk of side effects associated with high doses of HGH.
Trophic Support: Beyond just releasing GH, Sermorelin may actually provide trophic support for the pituitary gland itself, potentially preventing the age-related atrophy of GH-secreting cells.
Metabolic Synergism: Frequently studied in combination with GHRPs (like Ipamorelin) to observe the amplified effects of dual-signaling on the pituitary.

4. Technical Specifications (E-E-A-T Data)

Feature	Scientific Specification
Molecular Formula	$C_{149}H_{246}N_{44}O_{42}S$
Molecular Weight	3357.9 g/mol
CAS Number	86168-78-7
Purity Grade	$\geq$ 99% (HPLC/MS Verified)
Formulation	Lyophilized Acetate Salt
Stability	24 months at -20°C; 21 days refrigerated after reconstitution

5. Product FAQ (Schema-Ready)

Q: Is Sermorelin the same as GHRH?

A: Sermorelin is the functional part (first 29 amino acids) of the 44-amino acid GHRH. It is the shortest fragment known to possess the full biological potency of the larger molecule, making it more stable and easier to synthesize for research purposes.

Q: What is the benefit of Sermorelin in longevity research?

A: Researchers focus on Sermorelin for its potential to reverse “somatopause”—the natural decline of GH levels as an organism ages. By restoring youthful GH pulses, researchers observe improvements in bone density, skin elasticity, and muscle mass maintenance.